An Oral Formulation of the Probiotic, <i>Bacillus subtilis</i> HU58, Was Safe and Well Tolerated in a Pilot Study of Patients with Hepatic Encephalopathy.

Evid Based Complement Alternat Med · 2020 · PMC7345602 · PMID 32714397

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an overall trendno p-value reported

Regarding blood ammonia levels, the authors concluded that while there was an overall trend for a reduction with the use of probiotics, well-planned studies are needed to provide high-quality data in support of probiotic use.

also in 4,871 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.